When PTCH1 binds to the soluble ligand sonic hedgehog (SHH)—or inactivated by loss-of-function mutation, as in Gorlin’s syndrome—this inhibition on SMO is withdrawn and the pathway is turned on. The gene discussed is PTCH1; the disease is nevoid basal cell carcinoma syndrome.